J B Chemicals and Pharmaceuticals Research Report By CD Equisearch

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Jan 6, 2016.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    579
    Likes Received:
    55
    The stock currently trades at 19.8x FY16e EPS of Rs.14.04 and 18.1x FY17e EPS of Rs.15.35. Given, strong sales growth in domestic formulations market, sturdy rise in operating margins and healthy liquidity position, we retain our buy rating on the stock for the target price of Rs 353 (previous target of Rs 333) implying 23x FY17e earnings (peg ratio of 2), over the next 9-12 months. For more information, please refer to our earlier report dated July 20, 2015.
     

    Attached Files:

  2. RAMA MURTHY SASTRY CHALLA

    RAMA MURTHY SASTRY CHALLA Well-Known Member

    Joined:
    Sep 8, 2015
    Messages:
    3,688
    Likes Received:
    2,011
    @ Vidhi khanna ,

    Thank You Very Much , This is very Useful and Informative post ...
     
  3. Srouta Mukherjee

    Srouta Mukherjee Well-Known Member

    Joined:
    Mar 28, 2015
    Messages:
    1,898
    Likes Received:
    769
  4. RAMA MURTHY SASTRY CHALLA

    RAMA MURTHY SASTRY CHALLA Well-Known Member

    Joined:
    Sep 8, 2015
    Messages:
    3,688
    Likes Received:
    2,011
    Srouta Mukherjee likes this.
Loading...